loadpatents
Patent applications and USPTO patent grants for Yew; Nelson S..The latest application filed is for "methods of treating fatty liver disease".
Patent | Date |
---|---|
Method of treating polycystic kidney diseases with ceramide derivatives Grant 10,220,039 - Natoli , et al. | 2019-03-05 |
Methods of Treating Fatty Liver Disease App 20170281593 - Zhao; Hongmei ;   et al. | 2017-10-05 |
Method Of Treating Polycystic Kidney Diseases With Ceramide Derivatives App 20170258802 - Natoli; Thomas A. ;   et al. | 2017-09-14 |
Methods of treating fatty liver disease Grant 9,556,155 - Zhao , et al. January 31, 2 | 2017-01-31 |
Method of lowering blood glucose Grant 9,532,976 - Cheng , et al. January 3, 2 | 2017-01-03 |
Composition Of Erythrocytes Encapsulating Phenylalanine Hydroxylase And Therapeutic Use Thereof App 20160120956 - GODFRIN; Yann ;   et al. | 2016-05-05 |
Method Of Treating Polycystic Kidney Diseases With Ceramide Derivatives App 20150216872 - Natoli; Thomas A. ;   et al. | 2015-08-06 |
Method of Treating Diabetes Mellitus App 20150190373 - Cheng; Seng H. ;   et al. | 2015-07-09 |
Methods of Treating Fatty Liver Disease App 20150051261 - Zhao; Hongmei ;   et al. | 2015-02-19 |
Method of treating polycystic kidney diseases with ceramide derivatives Grant 8,912,177 - Natoli , et al. December 16, 2 | 2014-12-16 |
Methods of treating fatty liver disease Grant 8,716,327 - Zhao , et al. May 6, 2 | 2014-05-06 |
Method Of Treating Diabetes Mellitus App 20120022126 - Cheng; Seng H. ;   et al. | 2012-01-26 |
Methods of treating diabetes mellitus Grant 8,003,617 - Cheng , et al. August 23, 2 | 2011-08-23 |
Method Of Treating Polycystic Kidney Diseases With Ceramide Derivatives App 20100298317 - Natoli; Thomas A. ;   et al. | 2010-11-25 |
Compositions and methods for treating lysosomal storage disease App 20100041151 - Yew; Nelson S. ;   et al. | 2010-02-18 |
Methods of Treating Fatty Liver Disease App 20090105125 - Zhao; Hongmei ;   et al. | 2009-04-23 |
Methods of Treating Diabetes Mellitus App 20080161379 - Cheng; Seng H. ;   et al. | 2008-07-03 |
Use of cationic lipids to generate anti-tumor immunity App 20050176672 - Scheule, Ronald K. ;   et al. | 2005-08-11 |
CpG reduced plasmids and viral vectors App 20040053870 - Yew, Nelson S. ;   et al. | 2004-03-18 |
Methylation of plasmid vectors App 20030220277 - Yew, Nelson S. ;   et al. | 2003-11-27 |
Compositions and methods for treating lysosomal storage disease App 20030087868 - Yew, Nelson S. ;   et al. | 2003-05-08 |
CpG reduced plasmids and viral vectors App 20020065236 - Yew, Nelson S. ;   et al. | 2002-05-30 |
Cationic amphiphiles for intracellular delivery of therapeutic molecules Grant 6,383,814 - Lee , et al. May 7, 2 | 2002-05-07 |
METHYLATION AND/Or CpG REMOVAL OF PLASMID VECTORS App 20020042383 - YEW, NELSON S. ;   et al. | 2002-04-11 |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy Grant 6,071,890 - Scheule , et al. June 6, 2 | 2000-06-06 |
Compositions and method for treating lysosomal storage disease Grant 6,066,626 - Yew , et al. May 23, 2 | 2000-05-23 |
Cationic amphiphile/DNA complexes Grant 5,948,767 - Scheule , et al. September 7, 1 | 1999-09-07 |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules Grant 5,935,936 - Fasbender , et al. August 10, 1 | 1999-08-10 |
Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules Grant 5,910,487 - Yew , et al. June 8, 1 | 1999-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.